Emerald Health Therapeutics, Inc. EMHTF
Set alert
0.04 +0.04 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- —
- High
- —
1M chart
Signals (19)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 11, 2022 | 3 years ago |
| SMA: Bullish | Nov 11, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 11, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 8, 2022 | 3 years ago |
| SMA: Bearish | Nov 7, 2022 | 3 years ago |
| SMA: Bearish | Nov 7, 2022 | 3 years ago |
| SMA: Bullish | Nov 4, 2022 | 3 years ago |
| SMA: Bullish | Nov 4, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 4, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 3, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 2, 2022 | 4 years ago |
| MACD: Sell Signal | Nov 1, 2022 | 4 years ago |
| SMA: Bearish | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 20, 2022 | 4 years ago |
| SMA: Bearish | Oct 19, 2022 | 4 years ago |
| SMA: Bullish | Oct 18, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 18, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 17, 2022 | 4 years ago |
| SMA: Bearish | Oct 12, 2022 | 4 years ago |
News
- Skye Bioscience concludes merger with Emerald Health Therapeutics and unveils goals for 2022 and 2023
- Skye Bioscience says Emerald Health Therapeutics shareholders approve integration plan of arrangement; gets regulatory approval to begin first-in-human clinical study
- Skye Bioscience signs agreement to merge with Emerald Health Therapeutics
- Emerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On Pharmaceuticals
- Emerald Health Therapeutics Announces Chief Financial Officer Transition
- Emerald Health Therapeutics, Inc. (EMHTF) CEO Riaz Bandali on Q2 2021 Results - Earnings Call Transcript
- Emerald Health Therapeutics Reports 2021 Second Quarter Financial Results and Provides Corporate Update
- Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET
- Emerald Health Therapeutics Hires VP Sales & Marketing
- Emerald Health Therapeutics Executive Chairman Avtar Dhillon Resigns
Your note
Sign in to keep a note on EMHTF — it syncs with the Stock Master app.